Package 51655-633-84

{"route": ["ORAL"], "spl_id": "494f71ad-6adc-4022-e063-6394a90a650a", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["f32d5f04-4198-82a5-e053-2995a90a1841"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-633-21)", "package_ndc": "51655-633-21", "marketing_start_date": "20230531"}, {"sample": false, "description": "14 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-633-84)", "package_ndc": "51655-633-84", "marketing_start_date": "20230105"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "51655-633_494f71ad-6adc-4022-e063-6394a90a650a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "51655-633", "generic_name": "Valacyclovir Hydrochloride", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA090682", "marketing_category": "ANDA", "marketing_start_date": "20230105", "listing_expiration_date": "20271231"}